Viewing Study NCT00220922



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00220922
Status: COMPLETED
Last Update Posted: 2011-04-08
First Post: 2005-09-20

Brief Title: A Study to Evaluate the Impact on Skin Injection Site Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone
Sponsor: Teva Neuroscience Inc
Organization: Teva Branded Pharmaceutical Products RD Inc

Study Overview

Official Title: An Open-Label Randomized Single Cross-Over Study of Isopropyl Alcohol Wipes Versus No Injection Site Preparation on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone
Status: COMPLETED
Status Verified Date: 2011-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is designed to compare injection site reactions with or without the use of alcohol wipes prior to performing the patients daily Copaxone injection
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None